Core Laboratories (NYSE: CLB) reported Q4 EPS of $0.15, $0.12 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $129.24 million versus the consensus estimate of $139.94 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.